Skip to content
Tech Insights Blog

The Zimbabwean Government Declines ‘Unbalanced’ US Healthcare Assistance Deal Due to Information Fears

Medical aid illustration
The proposed US funding was intended for programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (£272m) over five years over the United States' demand for sensitive biological samples.

The decision became public after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".

An official representative has since clarified that the United States was requesting biological samples for research and commercial gain but was not willing to guarantee the resulting advantages from future medical innovations.

"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has called for more talks to secure a agreement acceptable to both sides so the country's vital HIV programme can proceed.

Broader Context

Zimbabwe's decision comes after a similar case in Kenya, where a court blocked a related health funding agreement after concerns were filed about the security of citizens' health data.

Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and responsibility.

Based on statements, Sixteen African countries have so far signed these new agreements, representing more than $18.3bn in new funding.

Details of the Declined Deal

The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana argued the proposed deal was "unequal".

"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might be developed from that shared data," his statement read.

"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the end products would be accessible to our people should a future health crisis emerge."

Sovereignty and Global Health

He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending structures previously set up through the global organization.

Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.

"This mechanism is designed to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.

"We are open to further discussions with our US partners on how subsequent collaboration could be designed in a manner that respects the sovereignty and interests of both nations."

Medical Community Reaction

Medical experts said it recognised the government's concerns, but recommended that negotiations should continue since much of the nation's Aids initiatives depended on external financing.

"Where technical issues arise, including those relating to information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.

This impasse emphasises the continuing challenges between accepting vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.

The writer

Kim Foster

A software engineer and tech writer passionate about AI, cybersecurity, and emerging technologies, sharing insights from industry experience.

Tech Insights Blog

Type to search articles.